Implementation of Evidence-based Breathing Retraining for Patients with Asthma in Region Zealand
NCT ID: NCT05531370
Last Updated: 2024-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
300 participants
INTERVENTIONAL
2022-06-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EFFORT Asthma: Effects of Diet and Exercise in Asthma
NCT02355964
Breathing Exercises in Asthma Targeting Dysfunctional Breathing
NCT03127059
Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes
NCT01079000
Academic Detailing About Asthma
NCT05442307
Breathing Training for Asthma
NCT00975273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is part of Exercise First-project, a collaboration of The National Health Service, Region Zealand and the research unit PROgrez, Department of Physiotherapy and Occupational Therapy at Næstved, Slagelse, Ringsted hospitals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing Retraining (BR)
Patients will receive three sessions (60 min, 30 min, 30 min) of breathing retraining (BR), 1-to-1 with a trained physiotherapist.
As preferred by the patient:
* Hybrid delivery mode of BR (H-BR): First session on-site at hospital/clinic for initial assessment and introduction, and following sessions online (MedComs VDX platform or equal; participants access using web cam and sound on smart phone, tablet, or pc).
* Ordinary delivery of BR: Three sessions on-site at hospital/clinic.
Breathing Retraining
Conforming the real-world setting, all participants will continue standard asthma care, i.e., acute and planned visits at GP or pulmonologist.
BR aims to normalize the inhaled volume, nasal inhalation, exhalation to the resting position of the chest (functional residual capacity, FRC), use of the diaphragm muscle, and to move lower parts of the chest in a frequency of 12-16 per minute. This pattern is initially trained in rest (e.g., side lying or sitting), then during physical activity (e.g., walking). Uncontrolled coughing, frequent yawning or sighing is handled by a suppression technique. Relaxation technique is introduced as a separate activity but to be combined with the breathing pattern method to be used in both resting and as possible during physical activity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathing Retraining
Conforming the real-world setting, all participants will continue standard asthma care, i.e., acute and planned visits at GP or pulmonologist.
BR aims to normalize the inhaled volume, nasal inhalation, exhalation to the resting position of the chest (functional residual capacity, FRC), use of the diaphragm muscle, and to move lower parts of the chest in a frequency of 12-16 per minute. This pattern is initially trained in rest (e.g., side lying or sitting), then during physical activity (e.g., walking). Uncontrolled coughing, frequent yawning or sighing is handled by a suppression technique. Relaxation technique is introduced as a separate activity but to be combined with the breathing pattern method to be used in both resting and as possible during physical activity.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incompletely controlled asthma or worse: Asthma Control Questionnaire (ACQ5) score ≥0.8;
* Residence (or asthma treatment program) in Region Zealand, Denmark;
* Able to read and understand Danish or available assistance to help understand information material, intervention content and respond to questionnaires.
Exclusion Criteria
* Unable to participate in the intervention due to physical or mental condition.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Naestved Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Søren T Skou, Prof.
Role: STUDY_CHAIR
Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark
Lars H Tang, Assoc.Prof.
Role: STUDY_CHAIR
Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark
Cecilie L Egholm, PostDoc.
Role: STUDY_CHAIR
Naestved-Slagelse-Ringsted Hospitals, Denmark
Uffe Bodtger, Prof.
Role: STUDY_CHAIR
Zealand University Hospital; University of Southern Denmark
Mike Thomas, Prof.
Role: STUDY_CHAIR
Primary Care Research University of Southampton, UK
Karen H Andreasson, Dr.
Role: PRINCIPAL_INVESTIGATOR
Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naestved Hospital
Næstved, Region Sjælland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMN-2022-01229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.